Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.